1. Shu-Rong Ma#, Qian Tong#, Yuan Lin#, Li-Bin Pan#, Jie Fu#, Ran Peng, Xian-Feng Zhang, Zhen-Xiong Zhao, Yang Li, Jin-Bo Yu, Lin Cong, Pei Han, Zheng-Wei Zhang, Hang Yu, Yan Wang* and Jian-Dong Jiang*. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota [J]. Signal Transduction and Targeted Therapy. 2022, 7:207.
2. Yan Wang#*, Qian Tong#, Shu-Rong Ma#, Zhen-Xiong Zhao#, Li-Bin Pan , Lin Cong, Pei Han, Ran Peng, Hang Yu, Yuan Lin, Tian-Le Gao, Jia-Wen Shou, Xiao-Yang Li, Xian-Feng Zhang, Zheng-Wei Zhang, Jie Fu, Bao-Ying Wen, Jin-Bo Yu, Xuetao Cao* and Jian-Dong Jiang*. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota [J]. Signal Transduction and Targeted Therapy. 2021, 24;6(1):1-20.
3. Li-Bin Pan#, Hang Yu#, Jie Fu#, Jia-Chun Hu, Hui Xu, Zheng-Wei Zhang, Meng-Meng Bu, Xin-Yu Yang, Hao-Jian Zhang, Jin-Yue Lu, Jian-Dong Jiang* and Yan Wang*. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota [J]. Acta Pharmaceutica Sinica B. 2023;13(4):1537-1553.
4. Xin-Yu Yang#, Hang Yu#, Jie Fu#, Hui-Hui Guo, Pei Han, Shu-Rong Ma, Li-Bin Pan, Zheng-Wei Zhang, Hui Xu, Jia-Chun Hu, Hao-Jian Zhang, Meng-Meng Bu, Xian-Feng Zhang, Wei Yang, Jing-Yue Wang, Jing-Yu Jin, Hui-Cong Zhang, Dong-Rui Li, Jin-Yue Lu, Yuan Lin*, Jian-Dong Jiang*, Qian Tong* and Yan Wang*. Hydroxyurea ameliorates atherosclerosis in ApoE -/- mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota [J]. Theranostics, 2022, 12(18): 7775-7787.
5. Zheng-Wei Zhang#, Chun-Sheng Gao#, Heng Zhang#, Jian Yang, Ya-Ping Wang, Li-Bin, Pan, Hang Yu, Chi-Yu He, Hai-Bin Luo, Zhen-Xiong Zhao, Xin-Bo Zhou, Yu-Li Wang, Jie Fu, Pei Han, Yu-hui Dong, Gang Wang, Song Li*, Yan Wang*, Jian-Dong Jiang* and Wu Zhong*. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota [J]. Acta Pharmaceutica Sinica B. 2022, 12(8):3298-3312.
6. Zheng-Wei Zhang#, Lin Cong#, Ran Peng, Pei Han, Shu-Rong Ma, Li-Bin Pan, Jie Fu, Hang Yu, Yan Wang* and Jian-Dong Jiang*. Transformation of Berberine to Its Demethylated Metabolites by the CYP51 Enzyme in the Gut Microbiota [J]. Journal of Pharmaceutical Analysis. 2021, 11(5):628-637.
7. Han P, Li LS, Wang ZX, Xi L, Yu H, Cong L, Zhang ZW, Fu J, Peng R, Pan LB, Ma SR. Wang XY, Wang HT*, Wang Y*, Sun JL*, Jiang JD*. Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering. 2021; 15: 115-125.
8. Shang J, Ma S, Zang CX, Bao XQ*, Wang Y*, Zhang D*. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson’s disease treatment. Acta Pharmaceutica Sinica B. 2021 May;11(5):1213-1226.
9. Pan L, Han P, Ma S, Peng R, Wang C, Kong W, Cong L, Fu J, Zhang Z, Yu H, Wang Y*, Jiang J.D*. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharmaceutica Sinica B. 2020 Feb;10(2):249-261.
10. Zhen-Xiong Zhao, Jie Fu, Shu-Rong Ma, Ran Peng, Jin-Bo Yu, Lin Cong, Li-Bin Pan, Zuo-Guang Zhang, Hui Tian, Chun-Tao Che, Yan Wang*, Jian-Dong Jiang*. Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 2018 Nov 13;8(21):5945-5959.
11. Yan Wang*, Qian Tong, Jia-Wen Shou, Zhen-Xiong Zhao, Xiao-Yang Li, Xian-Feng Zhang, Shu-Rong Ma, Chi-Yu He, Bao-Ying Wen, Fang Guo, Jie Fu, Jian-Dong Jiang*. Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine. Theranostics, 2017 June, 7(9): 2443-2451.
12. Yan Wang*, Jia-Wen Shou, Xiao-Yang Li, Zhen-Xiong Zhao, Jie Fu, Chi-Yu He, Ru Feng, Chao Ma, Bao-Ying Wen, Fang Guo, Xin-Yi Yang, Yan-Xing Han, Lu-Lu Wang, Qian Tong, Xue-Fu You, Yuan Lin, Wei-Jia Kong, Shu-Yi Si, Jian-Dong Jiang*. Berberine-induced bioactive metabolites of gut microbiota improves energy metabolism. Metabolism-clinical & Experimental, 2017 May, 70, 72–84.
13. Hang Yu, Baoying Wen, Min Huang, Ru Feng, Libin Pan, Manyi Xu, Hao Lin, Lin Cong, Sen Zhang, Yan Li, Chi-Hin Cho, Chongjing Zhang, Xiaoguang Chen, Yan Wang*. TCP-1, a novel peptide to diagnose early colon cancer. Chinese Chemical Letters, Available online 19 February 2023, https://doi.org/10.1016/j.cclet.2023.108235
14. Hui Xu #, Hang Yu #, Jie Fu, Zheng-Wei Zhang, Jia-Chun Hu, Jin-Yue Lu, Xin-Yu Yang, Meng-Meng Bu, Jian-Dong Jiang* and Yan Wang*. Metabolites analysis of plantamajoside based on gut microbiota-drug interaction [J]. Phytomedicine, 2023, 116:154841.
15. Hang Yu#, Hui Xu#, Xinyu Yang, Zhengwei Zhang, Jiachun Hu, Jinyue Lu, Jie Fu, Mengmeng Bu, Haojian Zhang, Zhao Zhai, Jingyue Wang, Jiandong Jiang*, Yan Wang*. Gut microbiota-based PK-PD study and molecular mechanism of Specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase. J Pharm Anal. 2023. Accepted. Doi: 10.1016/j.jpha.2023.06.012